1. 1) Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A, Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review, Eur J Clin Pharmacol, 2012, 68, 1243-1255.
2. 2) Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators, Acute renal failure in critically ill patients: a multinational, multicenter study, JAMA, 2005, 294, 813-818.
3. 3) Pazhayattil GS, Shirali AC, Drug-induced impairment of renal function, Int J Nephrol Renovasc Dis, 2014, 7, 457-468.
4. 4) Hellwig T, Hammerquist R, Loecker B, Shields J, Retrospective evaluation of the incidence of vancomycin and/or piperacillin-tazobactam induced acute renal failure, Critical Care Medicine, 2011, 39, 79.
5. 5) Min E, Box K, Lane J, Sanchez J, Coimbra R, Doucet J, Potenza B, Wargel L, Acute kidney injury in patients receiving concomitant vancomycin and piperacillin/tazobactam, Critical Care Medicine, 2011, 39, 200.